Pyxis Oncology, Inc. (PYXS) Operating cash flow 2020–2025
Pyxis Oncology, Inc. (PYXS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$63.5MFY2025 · since FY2020: -$10.1M → -$63.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63.5M | -10.1% |
| FY2024 | -$57.7M | +18.4% |
| FY2023 | -$70.7M | +20.8% |
| FY2022 | -$89.3M | -152.9% |
| FY2021 | -$35.3M | -250.3% |
| FY2020 | -$10.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice